Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 35 | 2024 | 8730 | 1.860 |
Why?
|
| Amyloid beta-Peptides | 19 | 2024 | 3896 | 0.930 |
Why?
|
| Neural Stem Cells | 6 | 2021 | 898 | 0.840 |
Why?
|
| Neurogenesis | 7 | 2023 | 866 | 0.830 |
Why?
|
| Presenilin-1 | 11 | 2020 | 665 | 0.800 |
Why?
|
| Amyloid Precursor Protein Secretases | 7 | 2022 | 618 | 0.710 |
Why?
|
| Neprilysin | 1 | 2023 | 484 | 0.700 |
Why?
|
| Cell Culture Techniques | 4 | 2016 | 1652 | 0.690 |
Why?
|
| Hippocampus | 9 | 2023 | 3775 | 0.560 |
Why?
|
| Amyloid beta-Protein Precursor | 9 | 2022 | 1116 | 0.540 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2018 | 605 | 0.460 |
Why?
|
| Fibronectins | 3 | 2023 | 719 | 0.430 |
Why?
|
| Microglia | 4 | 2021 | 1372 | 0.400 |
Why?
|
| Cognition | 7 | 2023 | 7049 | 0.370 |
Why?
|
| Dentate Gyrus | 3 | 2008 | 166 | 0.360 |
Why?
|
| Plaque, Amyloid | 4 | 2020 | 772 | 0.310 |
Why?
|
| Astrocytes | 5 | 2024 | 1345 | 0.290 |
Why?
|
| Memory | 6 | 2006 | 2190 | 0.280 |
Why?
|
| Mice, Transgenic | 12 | 2024 | 9550 | 0.270 |
Why?
|
| Physical Conditioning, Animal | 2 | 2021 | 366 | 0.260 |
Why?
|
| Maze Learning | 4 | 2008 | 482 | 0.260 |
Why?
|
| Neurons | 12 | 2024 | 9525 | 0.260 |
Why?
|
| Prealbumin | 1 | 2007 | 266 | 0.240 |
Why?
|
| Mice | 30 | 2024 | 81819 | 0.210 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2024 | 146 | 0.210 |
Why?
|
| Brain | 11 | 2024 | 27171 | 0.210 |
Why?
|
| Space Perception | 1 | 2006 | 469 | 0.200 |
Why?
|
| Exercise | 1 | 2018 | 5937 | 0.190 |
Why?
|
| Graphite | 1 | 2022 | 79 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 691 | 0.190 |
Why?
|
| Peptide Fragments | 6 | 2024 | 5125 | 0.180 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2022 | 309 | 0.180 |
Why?
|
| Coculture Techniques | 1 | 2024 | 1336 | 0.180 |
Why?
|
| Disease Models, Animal | 15 | 2024 | 18293 | 0.170 |
Why?
|
| Cell Differentiation | 7 | 2018 | 11641 | 0.170 |
Why?
|
| Interleukin-3 | 1 | 2021 | 423 | 0.170 |
Why?
|
| Models, Biological | 2 | 2024 | 9443 | 0.170 |
Why?
|
| Adult Stem Cells | 2 | 2013 | 221 | 0.170 |
Why?
|
| Animals | 37 | 2024 | 168764 | 0.160 |
Why?
|
| Choline | 1 | 2001 | 510 | 0.160 |
Why?
|
| Cell Death | 4 | 2018 | 1679 | 0.150 |
Why?
|
| Motor Activity | 1 | 2008 | 2704 | 0.150 |
Why?
|
| Blood-Brain Barrier | 1 | 2024 | 1037 | 0.150 |
Why?
|
| Cell Proliferation | 5 | 2018 | 10429 | 0.140 |
Why?
|
| Hormones | 1 | 2021 | 863 | 0.140 |
Why?
|
| Carbazoles | 1 | 2018 | 229 | 0.130 |
Why?
|
| Memory Disorders | 2 | 2023 | 1194 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2023 | 2927 | 0.130 |
Why?
|
| Learning | 2 | 2023 | 1755 | 0.130 |
Why?
|
| Stem Cells | 1 | 2008 | 3540 | 0.120 |
Why?
|
| Cells, Cultured | 10 | 2024 | 18973 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 2880 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2020 | 822 | 0.110 |
Why?
|
| Mice, Knockout | 8 | 2021 | 14448 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2019 | 1415 | 0.100 |
Why?
|
| Presenilin-2 | 3 | 2008 | 100 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2014 | 563 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 414 | 0.100 |
Why?
|
| Neurites | 1 | 2014 | 389 | 0.100 |
Why?
|
| tau Proteins | 3 | 2024 | 2112 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 4044 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 242 | 0.100 |
Why?
|
| Interleukin-6 | 2 | 2019 | 3222 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3584 | 0.090 |
Why?
|
| Mice, Inbred C3H | 2 | 2013 | 914 | 0.090 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 11888 | 0.090 |
Why?
|
| Neuroprotective Agents | 3 | 2002 | 959 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3430 | 0.090 |
Why?
|
| Alkaloids | 2 | 2003 | 190 | 0.090 |
Why?
|
| Gliosis | 3 | 2013 | 247 | 0.090 |
Why?
|
| Mice, Inbred ICR | 3 | 2006 | 339 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 1066 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 1333 | 0.080 |
Why?
|
| Enzyme Inhibitors | 3 | 2017 | 3715 | 0.080 |
Why?
|
| Lateral Ventricles | 1 | 2010 | 142 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 762 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 3690 | 0.080 |
Why?
|
| Models, Neurological | 2 | 2015 | 1747 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 3819 | 0.080 |
Why?
|
| Humans | 29 | 2024 | 765968 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 5849 | 0.070 |
Why?
|
| Scopolamine | 2 | 2006 | 92 | 0.070 |
Why?
|
| Rats | 10 | 2024 | 23707 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 6547 | 0.070 |
Why?
|
| Muscarinic Antagonists | 2 | 2006 | 133 | 0.070 |
Why?
|
| Splenomegaly | 1 | 2007 | 192 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2021 | 2666 | 0.070 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 1477 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 488 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 752 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 22332 | 0.060 |
Why?
|
| Prosencephalon | 1 | 2008 | 305 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2010 | 752 | 0.060 |
Why?
|
| Nerve Degeneration | 2 | 2007 | 748 | 0.060 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 380 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 4137 | 0.060 |
Why?
|
| Bromodeoxyuridine | 3 | 2010 | 310 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2013 | 2589 | 0.060 |
Why?
|
| Microfluidics | 1 | 2009 | 651 | 0.050 |
Why?
|
| Amyloid | 1 | 2009 | 853 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1718 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2014 | 8278 | 0.050 |
Why?
|
| Autoradiography | 1 | 2024 | 723 | 0.050 |
Why?
|
| Social Environment | 1 | 2008 | 1011 | 0.050 |
Why?
|
| Kynurenine | 1 | 2004 | 142 | 0.050 |
Why?
|
| Polygala | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cognition Disorders | 3 | 2021 | 3967 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2024 | 543 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 123 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2022 | 12131 | 0.050 |
Why?
|
| Cell Survival | 4 | 2013 | 5747 | 0.050 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2002 | 241 | 0.050 |
Why?
|
| Pericytes | 1 | 2024 | 299 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 1240 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2013 | 7851 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2001 | 227 | 0.050 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2001 | 63 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 4 | 2010 | 4392 | 0.050 |
Why?
|
| Cues | 1 | 2006 | 877 | 0.040 |
Why?
|
| Sodium Glutamate | 1 | 2000 | 22 | 0.040 |
Why?
|
| Phytotherapy | 1 | 2002 | 298 | 0.040 |
Why?
|
| Food Additives | 1 | 2000 | 23 | 0.040 |
Why?
|
| Neurotoxins | 1 | 2001 | 238 | 0.040 |
Why?
|
| Tubulin | 1 | 2023 | 692 | 0.040 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2022 | 252 | 0.040 |
Why?
|
| Male | 13 | 2024 | 363698 | 0.040 |
Why?
|
| Acute-Phase Reaction | 1 | 2019 | 90 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2000 | 262 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2001 | 626 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2023 | 708 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2002 | 496 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2023 | 777 | 0.040 |
Why?
|
| Mitochondria | 2 | 2002 | 3673 | 0.040 |
Why?
|
| Mutation | 4 | 2015 | 30198 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2016 | 1560 | 0.040 |
Why?
|
| Adult | 2 | 2023 | 223044 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2000 | 576 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 1490 | 0.040 |
Why?
|
| Receptors, Nicotinic | 1 | 2001 | 494 | 0.040 |
Why?
|
| Allosteric Site | 1 | 2017 | 106 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2007 | 4159 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2001 | 1137 | 0.030 |
Why?
|
| Behavior, Animal | 2 | 2021 | 1865 | 0.030 |
Why?
|
| Peptides | 1 | 2009 | 4331 | 0.030 |
Why?
|
| Disease Progression | 3 | 2008 | 13632 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2004 | 2599 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20124 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2019 | 700 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2010 | 23601 | 0.030 |
Why?
|
| Nicotine | 1 | 2001 | 682 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2000 | 718 | 0.030 |
Why?
|
| Cricetulus | 1 | 2017 | 805 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2000 | 993 | 0.030 |
Why?
|
| CHO Cells | 1 | 2017 | 1372 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 18071 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 1445 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2024 | 1855 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2024 | 2699 | 0.030 |
Why?
|
| Estradiol | 1 | 2001 | 1947 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2020 | 2341 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 348 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 1520 | 0.030 |
Why?
|
| Survival Rate | 1 | 2007 | 12795 | 0.030 |
Why?
|
| Cytokines | 1 | 2008 | 7421 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2242 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2013 | 284 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 419 | 0.020 |
Why?
|
| Female | 7 | 2024 | 396112 | 0.020 |
Why?
|
| Age Factors | 3 | 2018 | 18380 | 0.020 |
Why?
|
| Apoptosis | 2 | 2004 | 9514 | 0.020 |
Why?
|
| PC12 Cells | 2 | 2001 | 317 | 0.020 |
Why?
|
| Caspases | 2 | 2004 | 880 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2004 | 2895 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2017 | 3946 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7584 | 0.020 |
Why?
|
| Miniaturization | 1 | 2009 | 150 | 0.020 |
Why?
|
| Silver Staining | 1 | 2008 | 62 | 0.020 |
Why?
|
| Dementia | 1 | 2003 | 2744 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2003 | 8102 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 36532 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 4908 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 1151 | 0.020 |
Why?
|
| Cell Line | 2 | 2015 | 15543 | 0.020 |
Why?
|
| Sample Size | 1 | 2009 | 845 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 5767 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11022 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 2548 | 0.010 |
Why?
|
| Synucleins | 1 | 2004 | 108 | 0.010 |
Why?
|
| Cell Division | 2 | 2003 | 4475 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2060 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3081 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1823 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16721 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2004 | 308 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5743 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 244 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6203 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2013 | 22223 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2003 | 525 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2003 | 1300 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2001 | 150 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 2000 | 44 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2002 | 562 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 456 | 0.010 |
Why?
|
| Hemolysis | 1 | 2003 | 406 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 731 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2002 | 450 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2000 | 395 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2002 | 778 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2001 | 512 | 0.010 |
Why?
|
| Nervous System | 1 | 2003 | 542 | 0.010 |
Why?
|
| S Phase | 1 | 2000 | 424 | 0.010 |
Why?
|
| Respiratory System | 1 | 2003 | 559 | 0.010 |
Why?
|
| Fear | 1 | 2008 | 1499 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2003 | 931 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 3586 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 911 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 12768 | 0.010 |
Why?
|
| Avoidance Learning | 1 | 2000 | 248 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2002 | 733 | 0.010 |
Why?
|
| Entorhinal Cortex | 1 | 2000 | 285 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4520 | 0.010 |
Why?
|
| Amnesia | 1 | 2000 | 256 | 0.010 |
Why?
|
| alpha-Synuclein | 1 | 2004 | 772 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2003 | 706 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2669 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2001 | 963 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2002 | 1180 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 4734 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 2140 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 1500 | 0.010 |
Why?
|
| Fetus | 1 | 2002 | 1870 | 0.010 |
Why?
|
| Microtubules | 1 | 2000 | 1062 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 2000 | 970 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2000 | 1673 | 0.010 |
Why?
|
| Aging | 1 | 2013 | 8731 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3750 | 0.010 |
Why?
|
| Synapses | 1 | 2003 | 1754 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 16047 | 0.010 |
Why?
|
| Reaction Time | 1 | 2000 | 2086 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2001 | 2485 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2001 | 2143 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 4184 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2867 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10729 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 2003 | 4544 | 0.000 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 17075 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 14751 | 0.000 |
Why?
|
| Pregnancy | 1 | 2000 | 30260 | 0.000 |
Why?
|
Concepts
(250)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_